Dr. Naveen Rajpurohit, MD

Dr. Rajpurohit practices at Sanford Cardiovascular Institute - HOPD in Sioux Falls, South Dakota.

Dr. Rajpurohit's NPI, 1235369950, was assigned on July 15, 2009. Dr. Rajpurohit holds South Dakota license 8419.

Dr. Rajpurohit's primary practice is Sanford Cardiovascular Institute - HOPD, at 1301 W 18th St, Sioux Falls, SD 57105.

Dr. Rajpurohit's primary practice is Sanford Cardiovascular Institute - HOPD in Sioux Falls, South Dakota. Dr. Rajpurohit is also affiliated with Sanford USD Medical Center. The medical group on file is Edith Sanford Breast Center Sioux Falls. Dmand AI also links Dr. Rajpurohit to 4 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account. Dr. Rajpurohit's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rajpurohit practices, 9 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Rajpurohit's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Rajpurohit's licenses on file in 2 states: South Dakota and Missouri.

CMS data shows 5,520 Medicare services from Dr. Rajpurohit across 35 procedure codes in 2024, for 1,882 Medicare patients. Medicare paid $228,904 for them.

CMS counts 1,882 Medicare patients who saw Dr. Rajpurohit in 2024. The largest group is 65 to 74, with 790 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rajpurohit's median patient age at 76, with 48% women.

In 2024, Dr. Rajpurohit wrote 3,191 Medicare Part D claims for 783 patients. 81% of them were for generic drugs. CMS names the drug for 3,050 of them, across 36 drugs with 11 or more claims each, at $690,048 in total drug cost. In 2023, CMS named 2,294 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Rajpurohit for performance year 2024, reported through an alternative payment model (APM). Dr. Rajpurohit accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 24 papers to Dr. Rajpurohit, published from 2011 to 2021. 2011 was the busiest year, with 2. The most frequent topics are Myocardial Infarction, Acute Coronary Syndrome and Cardiac Catheterization. Dr. Rajpurohit has published most often in S D Med. Dr. Rajpurohit's most frequent co-authors are Adam Tomasz Stys, MD, Tomasz P. Stys, MD and Martin A. Alpert, MD.

CMS Open Payments shows 134 general payments to Dr. Rajpurohit from 18 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 89% of the total. Janssen Pharmaceuticals, Inc paid the most, $66,824.